Free Trial

Danaher (DHR) Stock Price, News & Analysis

Danaher logo
$185.87 +1.03 (+0.56%)
Closing price 03:59 PM Eastern
Extended Trading
$185.94 +0.07 (+0.04%)
As of 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Danaher Stock (NYSE:DHR)

Advanced

Key Stats

Today's Range
$183.45
$186.80
50-Day Range
$181.56
$212.24
52-Week Range
$171.00
$279.41
Volume
3.51 million shs
Average Volume
4.17 million shs
Market Capitalization
$133.09 billion
P/E Ratio
39.55
Dividend Yield
0.69%
Price Target
$245.91
Consensus Rating
Moderate Buy

Company Overview

Danaher Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
100th Percentile Overall Score

DHR MarketRank™: 

Danaher scored higher than 100% of companies evaluated by MarketBeat, and ranked 7th out of 743 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Danaher has received a consensus rating of Moderate Buy. The company's average rating score is 2.85, and is based on 17 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside Potential

    Danaher has a consensus price target of $245.91, representing about 32.1% upside from its current price of $186.20.

  • Amount of Analyst Coverage

    Danaher has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Danaher's stock forecast and price target.
  • Earnings Growth

    Earnings for Danaher are expected to grow by 12.32% in the coming year, from $7.63 to $8.57 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Danaher is 39.64, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 281.37.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Danaher is 39.64, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 75.61.

  • Price to Earnings Growth Ratio

    Danaher has a PEG Ratio of 2.63. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Danaher has a P/B Ratio of 2.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Danaher's valuation and earnings.
  • Percentage of Shares Shorted

    1.46% of the float of Danaher has been sold short.
  • Short Interest Ratio / Days to Cover

    Danaher has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Danaher has recently increased by 0.84%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Danaher has a dividend yield of 0.69%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Danaher has only been increasing its dividend for 2 years.

  • Dividend Coverage

    The dividend payout ratio of Danaher is 27.23%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Danaher will have a dividend payout ratio of 14.94% next year. This indicates that Danaher will be able to sustain or increase its dividend.

  • Read more about Danaher's dividend.
  • Percentage of Shares Shorted

    1.46% of the float of Danaher has been sold short.
  • Short Interest Ratio / Days to Cover

    Danaher has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Danaher has recently increased by 0.84%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Danaher has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.02 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 45 news articles for Danaher this week, compared to 49 articles on an average week.
  • Search Interest

    52 people have searched for DHR on MarketBeat in the last 30 days. This is an increase of 225% compared to the previous 30 days.
  • MarketBeat Follows

    25 people have added Danaher to their MarketBeat watchlist in the last 30 days. This is an increase of 257% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Danaher insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $586,325.00 in company stock.

  • Percentage Held by Insiders

    11.20% of the stock of Danaher is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    79.05% of the stock of Danaher is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Danaher's insider trading history.
Receive DHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DHR Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
See More Headlines

DHR Stock Analysis - Frequently Asked Questions

Danaher's stock was trading at $229.55 at the beginning of the year. Since then, DHR stock has decreased by 18.9% and is now trading at $186.2020.

Danaher Corporation (NYSE:DHR) posted its quarterly earnings data on Tuesday, July, 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher's quarterly revenue was up 3.4% on a year-over-year basis.
Read the conference call transcript
.

Danaher subsidiaries include these companies: Aldevron, Precision NanoSystems, Aquatic Informatics, Cytiva, GE Biopharma, Integrated DNA Technologies, IDBS Group, and others.

Shares of DHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Danaher investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), UnitedHealth Group (UNH), BlackRock (BLK), JPMorgan Chase & Co. (JPM) and Advanced Micro Devices (AMD).

Company Calendar

Record date for 7/25 Dividend
6/27/2025
Last Earnings
7/22/2025
Dividend Payable
7/25/2025
Record date for 10/31 Dividend
9/26/2025
Ex-Dividend for 10/31 Dividend
9/26/2025
Today
9/29/2025
Next Earnings (Estimated)
10/21/2025
Dividend Payable
10/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Industrial Conglomerates
Current Symbol
NYSE:DHR
CIK
313616
Employees
63,000
Year Founded
1984

Price Target and Rating

High Price Target
$315.00
Low Price Target
$205.00
Potential Upside/Downside
+32.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.85
Research Coverage
20 Analysts

Profitability

EPS (Trailing Twelve Months)
$4.70
Trailing P/E Ratio
39.61
Forward P/E Ratio
24.39
P/E Growth
2.63
Net Income
$3.90 billion
Net Margins
14.21%
Pretax Margin
16.97%
Return on Equity
10.70%
Return on Assets
6.85%

Debt

Debt-to-Equity Ratio
0.32
Current Ratio
1.62
Quick Ratio
1.22

Sales & Book Value

Annual Sales
$23.88 billion
Price / Sales
5.58
Cash Flow
$11.00 per share
Price / Cash Flow
16.92
Book Value
$68.60 per share
Price / Book
2.71

Miscellaneous

Outstanding Shares
716,050,000
Free Float
635,854,000
Market Cap
$133.25 billion
Optionable
Optionable
Beta
0.75

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:DHR) was last updated on 9/29/2025 by MarketBeat.com Staff
From Our Partners